Quinacrine treatment trial for sporadic Creutzfeldt-Jakob disease

OBJECTIVE: To determine whether oral quinacrine increases survival in sporadic Creutzfeldt-Jakob disease (sCJD). METHODS: This NIH/National Institute on Aging–funded, double-blinded, placebo-controlled, stratified randomization treatment trial was conducted at the University of California, San Franc...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Geschwind, Michael D., Kuo, Amy L., Wong, Katherine S., Haman, Aissa, Devereux, Gillian, Raudabaugh, Benjamin J., Johnson, David Y., Torres-Chae, Charles C., Finley, Ron, Garcia, Paul, Thai, Julie N., Cheng, Hugo Q., Neuhaus, John M., Forner, Sven A., Duncan, Jacque L., Possin, Katherine L., DeArmond, Stephen J., Prusiner, Stanley B., Miller, Bruce L.
Natura: Artigo
Lingua:Inglês
Pubblicazione: Lippincott Williams & Wilkins 2013
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4211922/
https://ncbi.nlm.nih.gov/pubmed/24122181
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1212/WNL.0b013e3182a9f3b4
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi